全文获取类型
收费全文 | 1841篇 |
免费 | 227篇 |
国内免费 | 1篇 |
专业分类
2069篇 |
出版年
2022年 | 10篇 |
2021年 | 27篇 |
2020年 | 18篇 |
2019年 | 15篇 |
2018年 | 24篇 |
2017年 | 27篇 |
2016年 | 50篇 |
2015年 | 62篇 |
2014年 | 78篇 |
2013年 | 93篇 |
2012年 | 104篇 |
2011年 | 96篇 |
2010年 | 67篇 |
2009年 | 61篇 |
2008年 | 95篇 |
2007年 | 95篇 |
2006年 | 84篇 |
2005年 | 88篇 |
2004年 | 87篇 |
2003年 | 96篇 |
2002年 | 79篇 |
2001年 | 52篇 |
2000年 | 55篇 |
1999年 | 44篇 |
1998年 | 32篇 |
1997年 | 21篇 |
1996年 | 25篇 |
1995年 | 23篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 38篇 |
1991年 | 28篇 |
1990年 | 30篇 |
1989年 | 20篇 |
1988年 | 23篇 |
1987年 | 25篇 |
1986年 | 21篇 |
1985年 | 19篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1978年 | 8篇 |
1976年 | 9篇 |
1975年 | 17篇 |
1974年 | 15篇 |
1973年 | 14篇 |
1972年 | 11篇 |
1970年 | 9篇 |
1968年 | 15篇 |
1967年 | 10篇 |
1966年 | 8篇 |
排序方式: 共有2069条查询结果,搜索用时 15 毫秒
71.
Tibbles HE Vassilev A Wendorf H Schonhoff D Zhu D Lorenz D Waurzyniak B Liu XP Uckun FM 《The Journal of biological chemistry》2001,276(21):17815-17822
Here we provide experimental evidence that identifies JAK3 as one of the regulators of platelet function. Treatment of platelets with thrombin induced tyrosine phosphorylation of the JAK3 target substrates STAT1 and STAT3. Platelets from JAK3-deficient mice displayed a decrease in tyrosine phosphorylation of STAT1 and STAT3. In accordance with these data, pretreatment of human platelets with the JAK3 inhibitor WHI-P131 markedly decreased the base-line enzymatic activity of constitutively active JAK3 and abolished the thrombin-induced tyrosine phosphorylation of STAT1 and STAT3. Following thrombin stimulation, WHI-P131-treated platelets did not undergo shape changes indicative of activation such as pseudopod formation. WHI-P131 inhibited thrombin-induced degranulation/serotonin release as well as platelet aggregation. Highly effective platelet inhibitory plasma concentrations of WHI-P131 were achieved in mice without toxicity. WHI-P131 prolonged the bleeding time of mice in a dose-dependent manner and improved event-free survival in a mouse model of thromboplastin-induced generalized and invariably fatal thromboembolism. To our knowledge, WHI-P131 is the first anti-thrombotic agent that prevents platelet aggregation by inhibiting JAK3. 相似文献
72.
73.
Yue Li Steven M. Shea Christine H. Lorenz Hangyi Jiang Ming-Chung Chou Susumu Mori 《PloS one》2013,8(10)
Due to the high sensitivity of diffusion tensor imaging (DTI) to physiological motion, clinical DTI scans often suffer a significant amount of artifacts. Tensor-fitting-based, post-processing outlier rejection is often used to reduce the influence of motion artifacts. Although it is an effective approach, when there are multiple corrupted data, this method may no longer correctly identify and reject the corrupted data. In this paper, we introduce a new criterion called “corrected Inter-Slice Intensity Discontinuity” (cISID) to detect motion-induced artifacts. We compared the performance of algorithms using cISID and other existing methods with regard to artifact detection. The experimental results show that the integration of cISID into fitting-based methods significantly improves the retrospective detection performance at post-processing analysis. The performance of the cISID criterion, if used alone, was inferior to the fitting-based methods, but cISID could effectively identify severely corrupted images with a rapid calculation time. In the second part of this paper, an outlier rejection scheme was implemented on a scanner for real-time monitoring of image quality and reacquisition of the corrupted data. The real-time monitoring, based on cISID and followed by post-processing, fitting-based outlier rejection, could provide a robust environment for routine DTI studies. 相似文献
74.
75.
Itten René Hischier Roland Andrae Anders S. G. Bieser Jan C. T. Cabernard Livia Falke Annemarie Ferreboeuf Hugues Hilty Lorenz M. Keller Regula L. Lees-Perasso Etienne Preist Chris Stucki Matthias 《The International Journal of Life Cycle Assessment》2020,25(10):2093-2098
The International Journal of Life Cycle Assessment - 相似文献
76.
77.
Urs Duthaler Michael Weber Lorenz Hofer Carlos Chaccour Marta Maia Pie Müller Stephan Krhenbühl Felix Hammann 《PLoS pathogens》2021,17(3)
Mosquitoes are vectors of major diseases such as dengue fever and malaria. Mass drug administration of endectocides to humans and livestock is a promising complementary approach to current insecticide-based vector control measures. The aim of this study was to establish an insect model for pharmacokinetic and drug-drug interaction studies to develop sustainable endectocides for vector control. Female Aedes aegypti mosquitoes were fed with human blood containing either ivermectin alone or ivermectin in combination with ketoconazole, rifampicin, ritonavir, or piperonyl butoxide. Drug concentrations were quantified by LC-MS/MS at selected time points post-feeding. Primary pharmacokinetic parameters and extent of drug-drug interactions were calculated by pharmacometric modelling. Lastly, the drug effect of the treatments was examined. The mosquitoes could be dosed with a high precision (%CV: ≤13.4%) over a range of 0.01–1 μg/ml ivermectin without showing saturation (R2: 0.99). The kinetics of ivermectin were characterised by an initial lag phase of 18.5 h (CI90%: 17.0–19.8 h) followed by a slow zero-order elimination rate of 5.5 pg/h (CI90%: 5.1–5.9 pg/h). By contrast, ketoconazole, ritonavir, and piperonyl butoxide were immediately excreted following first order elimination, whereas rifampicin accumulated over days in the mosquitoes. Ritonavir increased the lag phase of ivermectin by 11.4 h (CI90%: 8.7–14.2 h) resulting in an increased exposure (+29%) and an enhanced mosquitocidal effect. In summary, this study shows that the pharmacokinetics of drugs can be investigated and modulated in an Ae. aegypti animal model. This may help in the development of novel vector-control interventions and further our understanding of toxicology in arthropods. 相似文献
78.
Wolfgang Lorenz Constanze Buhrmann Ali Mobasheri Cora Lueders Mehdi Shakibaei 《Arthritis research & therapy》2013,15(5):R111
Introduction
We have previously reported that bacterial toxins, especially endotoxins such as lipopolysaccharides (LPS), might be important causative agents in the pathogenesis of rheumatoid arthritis (RA) in an in vitro model that simulates the potential effects of residing in damp buildings. Since numerous inflammatory processes are linked with the nuclear factor-κB (NF-κB), we investigated in detail the effects of LPS on the NF-κB pathway and the postulated formation of procollagen-endotoxin complexes.Methods
An in vitro model of human chondrocytes was used to investigate LPS-mediated inflammatory signaling.Results
Immunoelectron microscopy revealed that LPS physically interact with collagen type II in the extracellular matrix (ECM) and anti-collagen type II significantly reduced this interaction. BMS-345541 (a specific inhibitor of IκB kinase (IKK)) or wortmannin (a specific inhibitor of phosphatidylinositol 3-kinase (PI-3K)) inhibited the LPS-induced degradation of the ECM and apoptosis in chondrocytes. This effect was completely inhibited by combining BMS-345541 and wortmannin. Furthermore, BMS-345541 and/or wortmannin suppressed the LPS-induced upregulation of catabolic enzymes that mediate ECM degradation (matrix metalloproteinases-9, -13), cyclooxygenase-2 and apoptosis (activated caspase-3). These proteins are regulated by NF-κB, suggesting that the NF-κB and PI-3K pathways are involved in LPS-induced cartilage degradation. The induction of NF-κB correlated with activation of IκBα kinase, IκBα phosphorylation, IκBα degradation, p65 phosphorylation and p65 nuclear translocation. Further upstream, LPS induced the expression of Toll-like receptor 4 (TLR4) and bound with TLR4, indicating that LPS acts through TLR4.Conclusion
These results suggest that molecular associations between LPS/TLR4/collagen type II in chondrocytes upregulate the NF-κB and PI-3K signaling pathways and activate proinflammatory activity. 相似文献79.
80.
Mitja Lu?trek Peter Lorenz Michael Kreutzer Zilliang Qian Felix Steinbeck Di Wu Nadine Born Bjoern Ziems Michael Hecker Miri Blank Yehuda Shoenfeld Zhiwei Cao Michael O. Glocker Yixue Li Georg Fuellen Hans-Jürgen Thiesen 《PloS one》2013,8(11)
Epitope-antibody-reactivities (EAR) of intravenous immunoglobulins (IVIGs) determined for 75,534 peptides by microarray analysis demonstrate that roughly 9% of peptides derived from 870 different human protein sequences react with antibodies present in IVIG. Computational prediction of linear B cell epitopes was conducted using machine learning with an ensemble of classifiers in combination with position weight matrix (PWM) analysis. Machine learning slightly outperformed PWM with area under the curve (AUC) of 0.884 vs. 0.849. Two different types of epitope-antibody recognition-modes (Type I EAR and Type II EAR) were found. Peptides of Type I EAR are high in tyrosine, tryptophan and phenylalanine, and low in asparagine, glutamine and glutamic acid residues, whereas for peptides of Type II EAR it is the other way around. Representative crystal structures present in the Protein Data Bank (PDB) of Type I EAR are PDB 1TZI and PDB 2DD8, while PDB 2FD6 and 2J4W are typical for Type II EAR. Type I EAR peptides share predicted propensities for being presented by MHC class I and class II complexes. The latter interaction possibly favors T cell-dependent antibody responses including IgG class switching. Peptides of Type II EAR are predicted not to be preferentially presented by MHC complexes, thus implying the involvement of T cell-independent IgG class switch mechanisms. The high extent of IgG immunoglobulin reactivity with human peptides implies that circulating IgG molecules are prone to bind to human protein/peptide structures under non-pathological, non-inflammatory conditions. A webserver for predicting EAR of peptide sequences is available at www.sysmed-immun.eu/EAR. 相似文献